FDA implements new dietary supplement ingredient advisory list
The U.S. Food and Drug Administration (FDA) has unveiled its new Dietary Supplement Ingredient Advisory List, a rapid-response tool meant to quickly alert the public when the FDA identifies ingredients that do not appear to be lawfully marketed in dietary supplements.
The U.S. Food and Drug Administration (FDA) has unveiled its new Dietary Supplement Ingredient Advisory List, a rapid-response tool meant to quickly alert the public when the FDA identifies ingredients that do not appear to be lawfully marketed in dietary supplements. Consumers may wish to avoid buying and using products marketed as dietary supplements containing ingredients on this list, and industry may wish to avoid making or selling products marketed as dietary supplements containing these ingredients.
Ingredients are added to the Dietary Supplement Ingredient Advisory List based on a preliminary assessment by the FDA. The Dietary Supplement Ingredient Advisory List enables the FDA to communicate with the public while it completes a final determination regarding these ingredients. The list is not exhaustive and will be updated as ingredients are added to or removed from it. The FDA welcomes additional feedback and information, including information that may support or refute the FDA’s preliminary assessment, regarding the ingredients on the list. The FDA intends to communicate separately at any time that it identifies safety concerns about dietary ingredients or dietary supplements.